We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+2.36%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$26.2B
AUM Growth
+$914M
(+3.6%)
Cap. Flow
+$1.01B
Cap. Flow
% of AUM
3.87%
Top 10 Holdings %
Top 10 Hldgs %
32.55%
Holding
1,591
New
69
Increased
817
Reduced
431
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$107M |
| 2 |
EXL Service
EXLS
|
+$72M |
| 3 |
Apple
AAPL
|
+$64.3M |
| 4 |
Synopsys
SNPS
|
+$56.8M |
| 5 |
ServiceNow
NOW
|
+$54.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halozyme
HALO
|
+$74.5M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$53.5M |
| 3 |
Edwards Lifesciences
EW
|
+$45M |
| 4 |
Abbott
ABT
|
+$40.3M |
| 5 |
Rockwell Automation
ROK
|
+$39.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.4% |
| 2 | Healthcare | 16.63% |
| 3 | Financials | 12.04% |
| 4 | Communication Services | 9.47% |
| 5 | Industrials | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Ryan Specialty Holdings
RYAN
$11B
| $1.46M | 0.01% |
22,800
-1,600
| -7% | -$111K |
|
802
Selective Insurance
SIGI
$5.59B
| $1.46M | 0.01% |
15,616
| – | – |
|
803
Home BancShares
HOMB
$6.27B
| $1.46M | 0.01% |
51,555
+12,400
| +32% | +$358K |
|
804
Chewy
CHWY
$9.2B
| $1.45M | 0.01% |
43,400
-1,700
| -4% | -$52.9K |
|
|
PRMB
805
Primo Brands
PRMB
$8.97B
| $1.45M | 0.01% |
+47,141
| New | +$1.4M |
|
806
Post Holdings
POST
$3.65B
| $1.44M | 0.01% |
12,609
| – | – |
|
807
SLM Corp
SLM
$5.22B
| $1.43M | 0.01% |
51,779
+7,400
| +17% | +$183K |
|
808
Asbury Automotive
ABG
$3.78B
| $1.42M | 0.01% |
5,851
+700
| +14% | +$171K |
|
809
Hamilton Lane
HLNE
$5.91B
| $1.42M | 0.01% |
9,600
-1,800
| -16% | -$321K |
|
810
ACI Worldwide
ACIW
$5.42B
| $1.42M | 0.01% |
27,334
+2,700
| +11% | +$144K |
|
811
Cummins
CMI
$87B
| $1.42M | 0.01% |
4,067
+252
| +7% | +$88.5K |
|
812
Kontoor Brands
KTB
$4.65B
| $1.42M | 0.01% |
16,592
-300
| -2% | -$25.7K |
|
813
Corcept Therapeutics
CORT
$11.9B
| $1.41M | 0.01% |
27,981
-3,000
| -10% | -$157K |
|
814
Franklin Resources
BEN
$17.2B
| $1.41M | 0.01% |
69,300
+42,742
| +161% | +$900K |
|
815
Principal Financial Group
PFG
$24.6B
| $1.4M | 0.01% |
18,119
-15,855
| -47% | -$1.34M |
|
816
FNB Corp
FNB
$6.88B
| $1.4M | 0.01% |
94,631
| – | – |
|
817
GATX Corp
GATX
$6.33B
| $1.4M | 0.01% |
9,030
+700
| +8% | +$104K |
|
818
Independence Realty Trust
IRT
$4.01B
| $1.39M | 0.01% |
69,961
| – | – |
|
819
AerCap
AER
$23.5B
| $1.39M | 0.01% |
14,484
+493
| +4% | +$47.3K |
|
|
SEE
820
DELISTED
Sealed Air
SEE
| $1.38M | 0.01% |
40,900
+8,200
| +25% | +$293K |
|
821
Qualys
QLYS
$6.78B
| $1.38M | 0.01% |
9,851
+1,300
| +15% | +$181K |
|
822
Sterling Infrastructure
STRL
$16.9B
| $1.38M | 0.01% |
8,200
-600
| -7% | -$104K |
|
|
CADE
823
DELISTED
Cadence Bank
CADE
| $1.38M | 0.01% |
40,058
+6,400
| +19% | +$225K |
|
824
Macerich
MAC
$6.99B
| $1.38M | 0.01% |
69,256
+8,700
| +14% | +$170K |
|
|
BCPC
825
Balchem Corp
BCPC
$5.65B
| $1.38M | 0.01% |
8,451
+700
| +9% | +$121K |
|
Similar funds
GAM
Handelsbanken Fonder's Q4 2024 Portfolio in Review
As of Q4 2024, Handelsbanken Fonder held 1,591 positions worth $26.2B, up 3.6% from $25.3B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Handelsbanken Fonder deployed $1.01B of net new capital in Q4 2024, opening 69 new positions and adding to 817 existing holdings. Its largest new stake was GE Vernova: 105,537 shares worth $34.7M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 35% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Halozyme, an estimated $74.5M trimmed.
- Handelsbanken Fonder's largest Q4 2024 buy was GE Vernova: 105,537 shares worth $34.7M.
- Handelsbanken Fonder added most to Microsoft in Q4 2024, an estimated $107M increase.
- Handelsbanken Fonder's biggest Q4 2024 reduction was Halozyme, cutting an estimated $74.5M.
- Handelsbanken Fonder fully exited BeOne Medicines Ltd in Q4 2024, selling an estimated $5.92M.
- Handelsbanken Fonder's ten largest holdings make up 33% of its $26.2B portfolio in Q4 2024.
- Handelsbanken Fonder opened 69 new positions and closed 49 in Q4 2024.
- Handelsbanken Fonder's portfolio value rose 3.6% quarter-over-quarter to $26.2B.
Based on Handelsbanken Fonder's 13F filing for Q4 2024, filed 3 Feb 2025.